The {pharmaceutical market is currently exploring novel treatment strategies for obesity , and the introduction of semaglutide 10mg injectables represents a development . Clinicians are now consider the potential benefits and drawbacks associated with this increased potency version , notably in relation to existing lower-dose semaglutide products .